Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.44B | 8.78B | 8.18B | 7.72B | 7.53B | 8.00B |
Gross Profit | 377.25M | 575.98M | 482.25M | 412.57M | 278.40M | 487.52M |
EBITDA | 13.28M | 361.29M | 135.68M | 38.76M | -39.04M | 141.17M |
Net Income | -260.33M | 72.09M | 105.09M | 122.00M | -184.51M | 101.43M |
Balance Sheet | ||||||
Total Assets | 8.95B | 8.96B | 8.62B | 8.46B | 8.57B | 8.15B |
Cash, Cash Equivalents and Short-Term Investments | 1.28B | 1.31B | 1.42B | 1.46B | 1.57B | 1.15B |
Total Debt | 3.37B | 3.20B | 2.82B | 3.14B | 3.27B | 2.92B |
Total Liabilities | 6.68B | 6.43B | 6.14B | 6.05B | 6.23B | 5.66B |
Stockholders Equity | 2.20B | 2.46B | 2.44B | 2.38B | 2.29B | 2.46B |
Cash Flow | ||||||
Free Cash Flow | -14.85M | -632.71M | -23.20M | -132.14M | 72.16M | -1.02B |
Operating Cash Flow | 655.00K | -629.01M | -5.52M | -113.96M | 172.49M | -683.59M |
Investing Cash Flow | -9.72M | 94.67M | 219.25M | 163.54M | 84.06M | -217.34M |
Financing Cash Flow | 375.57M | 75.14M | -222.40M | -167.90M | 175.59M | 210.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £160.58B | 10.81 | 10.86% | 3.20% | -3.40% | -7.51% | |
76 Outperform | $520.85B | 36.91 | 27.96% | 2.37% | 19.20% | 24.01% | |
71 Outperform | HK$99.40B | 6.47 | 15.59% | 7.20% | 1.89% | 29.67% | |
67 Neutral | £2.83B | 10.37 | 4.69% | 3.46% | 2.40% | -24.53% | |
67 Neutral | $689.13B | 11.38 | 3.60% | -7.72% | -26.66% | ||
59 Neutral | $45.70B | 11.18 | 9.94% | 6.95% | 1.39% | -21.74% | |
56 Neutral | HK$794.51M | ― | -11.69% | 5.01% | 20.89% | -296.52% |